#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochromic anaemia Metastatic malignant melanoma CDKL5 deficiency disorder Extraskeletal ossification Ductal adenocarcinoma of pancreas Hepatocellular carcinoma Idiopathic pulmonary fibrosis Arteriosclerosis Fatty acid oxidation disorder Ureteric cancer Lymphangiosarcoma Piriformis syndrome Desmoplastic small round cell tumour Peripheral primitive neuroectodermal tumour of soft tissue Myelin oligodendrocyte glycoprotein antibody-associated disease More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Diagnostics Haemophagocytic lymphohistiocytosis – Basic Information Malignant fibrous histiocytoma – Life with Disease Nephroblastoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Basic Information Inclusion body myositis Nephroblastoma – Life with Disease Cholangitis sclerosing – Diagnostics Toxic epidermal necrolysis – Basic Information Splenic marginal zone lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AZD0292 Etoposide OMTX705 Caffeine Citrate Ripretinib Rosuvastatin Zinc Pabinafusp Alfa Anhydrous Docetaxel Neratinib Canakinumab ATIGOTATUG AMMONIUM (15N) CHLORIDE Esk-001 Aminocaproic Acid 177Lu-Rhpsma-10.1 Nicotine Mycophenolate Mofetil Iph6501 TRV045 VAMIFEPORT TRIHYDROCHLORIDE More therapies…

    Learn about Your Condition

    Genital herpes Relapsing multiple sclerosis Anaemia Alcoholic liver disease Haemolytic uraemic syndrome Transient ischaemic attack Persistent depressive disorder Ankylosing spondylitis Apheresis Oesophageal achalasia Blood disorder Somatic symptom disorder Tardive dyskinesia Cholecystitis acute Oesophageal food impaction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Study on Botulinum Toxin Type A Injection for Patients with Inability to Belch Due to Retrograde Cricopharyngeus Dysfunction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eructation
    • Oesophageal disorder
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Belgium

  • Study on Sodium Thiosulfate to Prevent Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Sodium Thiosulfate
    The Netherlands

  • Study on Mepolizumab and Nasal Polypectomy for Patients with Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    Spain

  • Study of Pembrolizumab and Chemotherapy for Patients with Locally Advanced Sinonasal Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nasal sinus cancer
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on Meniere’s Disease: Comparing Methylprednisolone and Placebo for Patients with Unilateral Meniere’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Deafness
    • Dizziness
    • Ear discomfort
    Investigated Drugs:
    • Gentamicin
    • Metoclopramide
    • Methylprednisolone
    The Netherlands

  • Study on [18F]PSMA-11 PET Imaging for Patients with Advanced Thyroid and Head and Neck Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Gozetotide Alf-18
    Belgium
Previous Page
1 2 3 4 5 6 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!